Novartis Seeks Dismissal Of FCA Kickback Claims

Law360, New York (June 16, 2014, 8:27 PM EDT) -- Novartis Pharmaceuticals Corp. asked a New York federal judge on Friday to chuck complaints accusing it of violating the False Claims Act by paying kickbacks to pharmacies, arguing that a whistleblower and the U.S. government failed to allege that the payments influenced physicians.

In two separate dismissal motions, Novartis argued that amended complaints filed by ex-employee David Kester and the federal government must be axed because they fail to allege that purported kickbacks to pharmacies Accredo Health Group Inc., Bioscrip Corp., Curascript Inc. and CVS Caremark Corp. influenced doctors’ decisions to prescribe various Novartis drugs.

“[The FCA] is violated only where...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!